These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3159937)

  • 1. Verapamil inhibition of lymphocyte proliferation and function in vitro.
    McMillen MA; Lewis T; Jaffe BM; Wait RB
    J Surg Res; 1985 Jul; 39(1):76-80. PubMed ID: 3159937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effect of a panel of membrane channel blockers on the proliferative, cytotoxic and cytoadherence abilities of human peripheral blood lymphocytes.
    Witkowski JM; Siebert J; Lukaszuk K; Trawicka L
    Immunopharmacology; 1993; 26(1):53-63. PubMed ID: 8407284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of verapamil on T-lymphocyte activation in vitro.
    Bruserud O
    Scand J Immunol; 1985 Jan; 21(1):73-9. PubMed ID: 3155874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of murine in vitro immune response by verapamil (V).
    Singh AB; Hiehle K; Casale P; Gerber S; Nayar S; Mann RA
    Immunopharmacology; 1990; 20(3):165-74. PubMed ID: 2149720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunosuppressive effects of verapamil upon mitogen activated and allo-antigen inducible human cytotoxic T-lymphocytes.
    Zanker B; Marx S; Strom TB; Köhler H
    Int J Immunopharmacol; 1994 Jul; 16(7):507-17. PubMed ID: 7928000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of R-verapamil on the cytokine environment and T-lymphocyte proliferation when human T-lymphocyte activation takes place in the presence of acute myelogenous leukemia blasts.
    Bruserud O
    Cancer Chemother Pharmacol; 1996; 39(1-2):71-8. PubMed ID: 8995502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early transmembrane events in alloimmune cytotoxic T-lymphocyte activation as revealed by stopped-flow fluorometry.
    Utsunomiya N; Tsuboi M; Nakanishi M
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1877-80. PubMed ID: 3081907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cytolytic T cell function by lectins.
    Toribio ML; de la Hera A; Pereira P; de Landázuri MO
    J Immunol; 1985 Apr; 134(4):2179-84. PubMed ID: 3871807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The appearance of cytotoxic lymphocytes in unstimulated and concanavalin A-activated human peripheral mononuclear cells.
    Persson U; Johansson SG
    Scand J Immunol; 1984 Sep; 20(3):209-17. PubMed ID: 6333717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interference of T cell activation by calcium channel blocking agents.
    Birx DL; Berger M; Fleisher TA
    J Immunol; 1984 Dec; 133(6):2904-9. PubMed ID: 6092460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetranactin, a macrotetrolide antibiotic, suppresses in vitro proliferation of human lymphocytes and generation of cytotoxicity.
    Callewaert DM; Radcliff G; Tanouchi Y; Shichi H
    Immunopharmacology; 1988; 16(1):25-32. PubMed ID: 2971634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of verapamil on cellular uptake, organ distribution, and pharmacology of cyclosporine.
    McMillen MA; Baumgarten WK; Schaefer HC; Mitchnick E; Fuortes M; Holman MJ; Tesi RJ
    Transplantation; 1987 Sep; 44(3):395-401. PubMed ID: 3629688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.
    Orosz CG; Fidelus RK; Roopenian DC; Widmer MB; Ferguson RM; Bach FH
    J Immunol; 1982 Nov; 129(5):1865-8. PubMed ID: 6214580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL; Lipsky PE
    J Immunol; 1986 Aug; 137(4):1399-406. PubMed ID: 3488348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cytotoxic T-lymphocyte activation by L-lactate and pyruvate.
    Mihm S; Dröge W
    Cell Immunol; 1985 Nov; 96(1):235-40. PubMed ID: 2941155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cytotoxic T lymphocytes and guinea pig ventricular myocytes. Pharmacological modulation by blocking K+ currents in cytotoxic T lymphocytes.
    Felzen B; Lavy R; Garcia M; Berke G; Gardner P; Binah O
    Circ Res; 1996 Feb; 78(2):253-61. PubMed ID: 8575069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential effect of 2-deoxyguanosine on concanavalin A-induced suppressor and cytotoxic activity.
    Varey AM; Lelchuk R; Hutchings P; Cooke A
    Cell Immunol; 1983 Oct; 81(1):99-104. PubMed ID: 6225531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.